Marc D. graduated from the University of Miami with a bachelor degree in science. He is 52 years old. Marc has over 25 years’ experience in diagnostics, biotechnology, and pharmaceuticals devices. In 2000, he founded Viacell (NASDAQ: VIAC). This was a biotechnology firm that worked in the preservation, development, and collection of umbilical cord blood stem cells. Marc D. managed the company for seven years. His hard work and commitment are seen through the company continuous growth. During Marc D. leadership the company had more than 300 employees, and the company was well known by the public.
Marc was appointed to be a member of the board of directors of Erytech Pharma. He also held a position of vice president of Global Marketing, where he was tasked with launching different products. In pharmaceutical and diagnostic divisions of laboratories (NYSE: ABT), Marc has worked in the marketing and sales department. He was also the chairman of the mpensation committee of Good start genetics. Marc is a member of the Miami university advisory council, and even he has served as a member of commercialization Advisory Committees.
Marc Beer was the founder of Renovia Inc. This company is located in Boston. FDA accepted the first products from Renovias company in April. Renovia company is committed to developing different therapeutic products and diagnostic methods to treat urinary incontinence. According to research conducted, this disorder affects over 250 women across the globe. Renovia is committed to developing a product with diagnostic and therapeutic potential to have a positive impact on the lives of the women. This company has received support from a different organization like Longwood fund.
Marc Beer has welcomed various organization to work together to improve the lives of many women who are affected by Urinary incontinence. According to Mr. Marc, when a different organization works together, they will be able to provide enough data to give the best treatment alternative. He believes with enough collection of data there will be a clear understanding of pelvic floor disorders. In addition, this will ensure the cost in healthcare is lowered.
Renovias technology enables treatment through clear visualization of pelvic movement. They have lowered the cost for pelvic floor disorder by using the digital healthcare. Currently, Renovia is the leading United States Company offering the best treatments for pelvic floor disorders and how to prevent this disorder. They have a mission to ensure many women who are affected by pelvic floor disorder can access medical treatment at a low cost. Mr. Marc has encouraged the employees to work together to deliver quality services to their daily clients. He has used the experience he has to make Renovias competitive in its operations across the world. Learn more : https://renoviainc.com/leadership/